These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9680137

  • 1. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
    Ibe M, Sakaguchi T, Tanaka K, Saito S, Yokota S, Tanaka T, Shimotohno K, Chujoh Y, Shiratori Y, Omata M, Miwa K, Takiguchi M.
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
    [Abstract] [Full Text] [Related]

  • 2. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A.
    J Immunol; 1999 Jan 15; 162(2):1156-64. PubMed ID: 9916747
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein.
    Kita H, Hiroishi K, Moriyama T, Okamoto H, Kaneko T, Ohnishi S, Yazaki Y, Imawari M.
    J Gen Virol; 1995 Dec 15; 76 ( Pt 12)():3189-93. PubMed ID: 8847528
    [Abstract] [Full Text] [Related]

  • 6. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L, Liu S, Fan GX, Sheng L, Ren HX, Yuan YK.
    Viral Immunol; 2006 Dec 15; 19(4):702-11. PubMed ID: 17201665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.
    Gut; 2006 Feb 15; 55(2):266-74. PubMed ID: 16105887
    [Abstract] [Full Text] [Related]

  • 9. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H, Miwa K, Shiga H, Moore YI, Oka S, Iwamoto A, Kaneko Y, Takiguchi M.
    J Immunol; 1997 May 15; 158(10):5026-34. PubMed ID: 9144523
    [Abstract] [Full Text] [Related]

  • 10. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
    Kurokohchi K, Arima K, Nishioka M.
    J Hepatol; 2001 Jun 15; 34(6):930-5. PubMed ID: 11451179
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
    Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, Ohnishi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M.
    Hepatology; 1997 Mar 15; 25(3):705-12. PubMed ID: 9049223
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
    Khanna R, Silins SL, Weng Z, Gatchell D, Burrows SR, Cooper L.
    Eur J Immunol; 1999 May 15; 29(5):1587-97. PubMed ID: 10359113
    [Abstract] [Full Text] [Related]

  • 13. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 14. [Forecasting of hepatitis C virus CTL epitopes and design of multi-epitopes vaccine].
    Li D, Xie YW, Xue XP, Bai XF, Jia ZS.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct 15; 17(10):786-7. PubMed ID: 19874698
    [No Abstract] [Full Text] [Related]

  • 15. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ, Wang WL, Wang T.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May 15; 20(3):325-7. PubMed ID: 15193229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ, Walker BD.
    Springer Semin Immunopathol; 1997 May 15; 19(1):69-83. PubMed ID: 9266632
    [Abstract] [Full Text] [Related]

  • 19. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.
    Hepatology; 2001 Jun 15; 33(6):1533-43. PubMed ID: 11391544
    [Abstract] [Full Text] [Related]

  • 20. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
    Sarobe P, Huarte E, Lasarte JJ, López-Díaz de Cerio A, García N, Borrás-Cuesta F, Prieto J.
    J Hepatol; 2001 Feb 15; 34(2):321-9. PubMed ID: 11281563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.